ES557391A0 - Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas) - Google Patents
Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas)Info
- Publication number
- ES557391A0 ES557391A0 ES557391A ES557391A ES557391A0 ES 557391 A0 ES557391 A0 ES 557391A0 ES 557391 A ES557391 A ES 557391A ES 557391 A ES557391 A ES 557391A ES 557391 A0 ES557391 A0 ES 557391A0
- Authority
- ES
- Spain
- Prior art keywords
- quinolins
- imidazolidin
- spiral
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/738,924 US4575507A (en) | 1985-05-29 | 1985-05-29 | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8801830A1 ES8801830A1 (es) | 1988-02-16 |
ES557391A0 true ES557391A0 (es) | 1988-02-16 |
Family
ID=24970055
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES555375A Expired ES8800228A1 (es) | 1985-05-29 | 1986-05-27 | Un procedimiento para la preparacion de espiro (imidiazolina-4,1'-(2'h)-naftaleno) y espiro (croman-4,4'-imidazolidinas) |
ES557391A Expired ES8801830A1 (es) | 1985-05-29 | 1987-02-13 | Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas) |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES555375A Expired ES8800228A1 (es) | 1985-05-29 | 1986-05-27 | Un procedimiento para la preparacion de espiro (imidiazolina-4,1'-(2'h)-naftaleno) y espiro (croman-4,4'-imidazolidinas) |
Country Status (21)
Country | Link |
---|---|
US (1) | US4575507A (es) |
EP (1) | EP0203791B1 (es) |
JP (1) | JPS61277671A (es) |
KR (1) | KR890001548B1 (es) |
AT (1) | ATE46332T1 (es) |
AU (1) | AU560429B2 (es) |
DD (5) | DD264213A5 (es) |
DE (1) | DE3665584D1 (es) |
DK (1) | DK248886A (es) |
EG (1) | EG17859A (es) |
ES (2) | ES8800228A1 (es) |
FI (1) | FI862251A (es) |
GR (1) | GR861388B (es) |
HU (4) | HU199845B (es) |
IL (1) | IL78954A (es) |
NO (1) | NO862123L (es) |
NZ (1) | NZ216334A (es) |
PH (1) | PH22213A (es) |
PL (5) | PL147399B1 (es) |
PT (1) | PT82650B (es) |
ZA (1) | ZA863934B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4680306A (en) * | 1984-07-20 | 1987-07-14 | Pfizer Inc. | Sprio-imidazolones for treatment of diabetes complications |
US4762839A (en) * | 1985-06-06 | 1988-08-09 | Tanabe Seiyaku Co., Ltd. | Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications |
JPS63132889A (ja) * | 1986-11-21 | 1988-06-04 | Tanabe Seiyaku Co Ltd | キナゾリノン誘導体 |
AU598366B2 (en) * | 1987-03-20 | 1990-06-21 | Alcon Laboratories, Inc. | Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes |
US5202339A (en) * | 1987-08-28 | 1993-04-13 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
US5004751A (en) * | 1987-08-28 | 1991-04-02 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
WO1990002126A1 (en) * | 1988-08-24 | 1990-03-08 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
US5068332A (en) * | 1990-10-12 | 1991-11-26 | American Home Products Corporation | Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors |
US8326636B2 (en) * | 2008-01-16 | 2012-12-04 | Canyon Ip Holdings Llc | Using a physical phenomenon detector to control operation of a speech recognition engine |
AU2013218119A1 (en) * | 2012-02-09 | 2014-07-17 | Boehringer Ingelheim International Gmbh | Method for stereoselective synthesis of 1,4-protected 9-hydroxy-5-oxo-1,4-diaza-spiro [5.5] undecanes |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4117230A (en) | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
ATE23046T1 (de) * | 1982-11-10 | 1986-11-15 | Pfizer | Sorbinil durch optische aufspaltung mit aminopinanderivaten. |
HU193191B (en) * | 1982-12-06 | 1987-08-28 | Pfizer | Process for preparing spiro-hetero-azolones |
US4556670A (en) | 1982-12-06 | 1985-12-03 | Pfizer Inc. | Spiro-3-hetero-azolones for treatment of diabetic complications |
EP0159143B1 (en) * | 1984-03-23 | 1987-12-16 | Pfizer Inc. | Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications |
US4762838A (en) | 1985-08-30 | 1988-08-09 | Pfizer Inc. | Quinazolin-4(3H)-one derivatives as anticoccidial agents |
-
1985
- 1985-05-29 US US06/738,924 patent/US4575507A/en not_active Expired - Lifetime
-
1986
- 1986-05-23 AT AT86303925T patent/ATE46332T1/de not_active IP Right Cessation
- 1986-05-23 EP EP86303925A patent/EP0203791B1/en not_active Expired
- 1986-05-23 DE DE8686303925T patent/DE3665584D1/de not_active Expired
- 1986-05-27 ES ES555375A patent/ES8800228A1/es not_active Expired
- 1986-05-27 ZA ZA863934A patent/ZA863934B/xx unknown
- 1986-05-27 DD DD86309078A patent/DD264213A5/de not_active IP Right Cessation
- 1986-05-27 PL PL1986266365A patent/PL147399B1/pl unknown
- 1986-05-27 DD DD86309079A patent/DD264214A5/de not_active IP Right Cessation
- 1986-05-27 PL PL1986266366A patent/PL147400B1/pl unknown
- 1986-05-27 PL PL1986266364A patent/PL147398B1/pl unknown
- 1986-05-27 DD DD86309080A patent/DD264215A5/de not_active IP Right Cessation
- 1986-05-27 PL PL1986259739A patent/PL146020B1/pl unknown
- 1986-05-27 PL PL1986266363A patent/PL147397B1/pl unknown
- 1986-05-27 PT PT82650A patent/PT82650B/pt not_active IP Right Cessation
- 1986-05-27 DD DD86290626A patent/DD251972A5/de not_active IP Right Cessation
- 1986-05-28 AU AU58012/86A patent/AU560429B2/en not_active Ceased
- 1986-05-28 HU HU893124A patent/HU199845B/hu unknown
- 1986-05-28 HU HU872418A patent/HUT49879A/hu unknown
- 1986-05-28 GR GR861388A patent/GR861388B/el unknown
- 1986-05-28 NZ NZ216334A patent/NZ216334A/xx unknown
- 1986-05-28 NO NO862123A patent/NO862123L/no unknown
- 1986-05-28 EG EG317/86A patent/EG17859A/xx active
- 1986-05-28 IL IL78954A patent/IL78954A/xx unknown
- 1986-05-28 KR KR8604182A patent/KR890001548B1/ko not_active IP Right Cessation
- 1986-05-28 DK DK248886A patent/DK248886A/da not_active Application Discontinuation
- 1986-05-28 FI FI862251A patent/FI862251A/fi not_active Application Discontinuation
- 1986-05-28 HU HU862249A patent/HU196060B/hu unknown
- 1986-05-29 JP JP61124608A patent/JPS61277671A/ja active Pending
- 1986-05-29 PH PH33830A patent/PH22213A/en unknown
-
1987
- 1987-02-13 ES ES557391A patent/ES8801830A1/es not_active Expired
- 1987-05-28 HU HU893127A patent/HU893127D0/hu unknown
- 1987-11-16 DD DD87309077A patent/DD273258A5/de not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES555147A0 (es) | Un procedimiento para la produccion de un compuesto de tiazolidindiona hipoglicemico | |
DK275488A (da) | Indolonderivater | |
GR3004278T3 (es) | ||
FI893632A0 (fi) | Foereningar. | |
ES557391A0 (es) | Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas) | |
ES2051834T3 (es) | El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad. | |
IE890177L (en) | Piperidinyl derivatives | |
SE8500996D0 (sv) | Method of treatment | |
ES528816A0 (es) | Procedimiento de producir compuestos para el tratamiento de la hipertension | |
EP0461681A3 (en) | Use of quinazolines in the preparation of a medicament for treating and preventing ischemic cardiac disease or arrhythmia | |
MX9205408A (es) | Metodo para tratar hipertension. |